ProQR Therapeutics B.V. Appoints As Chief Development Strategy Officer Post author:Sam Post published:March 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study May 7, 2017 Verastem Reports Year-End 2016 Financial Results March 23, 2017 NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented March 26, 2017
Catastrophic Year for Bay Area's OncoMed Continues as Lead Drug Comes Crashing Down in Phase II Study May 7, 2017
NeoTract, Inc.'s Minimally Invasive UroLift System For Enlarged Prostate Now Shown To Be Durable Through Five Years: Results From Pivotal L.I.F.T. Randomized Study Presented March 26, 2017